Fetal stem cell therapy for atherosclerosis at EmCell Cell Therapy Center in Kyiv, Ukraine, focuses on regenerating damaged vascular tissues. The clinic holds over 30 years of clinical experience as the first facility in the world dedicated to fetal stem cell treatments. This medical center operates with an ISO 15189 accreditation and a GMP-compliant laboratory to provide high safety standards for international patients.
The cardiovascular department is led by Dr. Mariia Klunnyk. She holds a PhD and focuses on regenerative medicine for heart diseases. Dr. Klunnyk has published peer-reviewed research on using fetal stem cells to treat chronic heart failure. Her work contributes to the clinic's patented protocols, which use a cryobank containing 20,000+ live fetal stem cell samples.
Before starting the therapy, patients undergo a series of tests to evaluate the condition of the heart and blood vessels. These diagnostics help the medical team track the severity of ischemia and vascular blockages.
The treatment uses intravenous and subcutaneous injections of fetal stem cell preparations. These cells travel through the bloodstream to reach damaged areas in the arterial walls. The therapy stimulates the formation of collateral vessels, which provide new paths for blood to bypass blocked arteries. This process helps reduce ischemia and improves the ability of the heart muscle to contract.
Clinical results from the center show that this method can extend life span by 35%. Patients often report a reduction in the frequency of angina attacks and a higher tolerance for physical activity. The procedure typically requires a stay of 2-3 days in Kyiv, often on an outpatient basis. The clinic provides free transfers from neighboring countries like Poland or Moldova to help with travel arrangements.
The goal of fetal stem cell therapy is to improve the patient's daily quality of life and heart function. The medical team monitors progress through follow-up tests and patient reports.
To learn more about the treatment process and travel support, you may request a consultation on Bookimed.
Individual treatment program and cost estimate
Average answering time – 5 minutes
| treatment | Price | |
|---|---|---|
| Pulmonary hypertension stem cell treatment | Price on request |
EmCell is recognized as the world’s first clinic to specialize in fetal stem cell therapy. With more than 30 years of clinical experience, the center has developed effective treatment protocols for conditions such as autism, diabetes, neurodegenerative disorders, and anti-aging. It began its work with treating aplastic anemia and continues expanding its expertise in regenerative medicine.
EmCell’s clinical department is led by medical doctors who were instrumental in developing the clinic’s patented fetal stem cell therapy. The team includes experienced neurologists, cardiologists, and general physicians, supported by skilled nurses and assistants. Comprehensive diagnostic evaluations—including ultrasound, ECG, EchoCG, Doppler studies, spirography, and densitometry—are conducted before treatment, followed by careful post-treatment monitoring to ensure safety and effectiveness.
The laboratory complex features a GMP-compliant Biotechnological Laboratory where fetal stem cell preparations are created using proprietary techniques. These preparations serve as the foundation of EmCell’s therapeutic programs. The department rigorously tests all materials throughout each stage, from donor screening to final release, to meet strict quality standards.
The PCR Laboratory performs real-time polymerase chain reaction testing to detect viral and bacterial pathogens such as HIV, HCV, HBV, CMV, HPV, and COVID-19, ensuring the safety of stem cell materials. EmCell also operates an ISO 15189-accredited Clinical-Diagnostic Laboratory offering a wide range of tests, including immunophenotyping, biochemical analysis, cytology, and hormone profiling.
The clinic maintains a cryobank housing over 20,000 live fetal stem cell samples preserved through advanced cryopreservation methods. This resource enables personalized treatment approaches and supports consistent clinical outcomes.
EmCell’s R&D division is dedicated to improving the efficacy of fetal stem cell therapies and expanding treatment options through continuous innovation and product development.
The clinic provides comprehensive patient support throughout the treatment journey. Each treatment package includes pick-up services from train or bus stations in Kyiv, daily transfers between the hotel and clinic, and interpreter support to facilitate clear communication with the medical team. Patients also undergo a series of examinations, such as abdominal and thyroid ultrasounds, ECG, and laboratory tests.
Following treatment, EmCell maintains long-term communication with each patient. A dedicated follow-up manager and the treating physician remain available to answer questions, provide additional recommendations, and track post-treatment progress.
Individual treatment program and cost estimate
Average answering time – 5 minutes